IDEAYA Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.69 billion, with shareholders equity totaling $1.09 billion.
The company employs approximately 62 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, IDEAYA Biosciences Inc. reported $25.66 million in revenue, generating net income of $-420.01 million.
Key financial metrics include a P/E ratio of -6.40, a price-to-book (P/B) ratio of 2.46, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IDYA.